Incyte’s Opzelura Meets Primary Endpoint in Eczema Trial, but Safety Concerns Persist

July 15, 2023

Blood Pressure medication recalled due to cancer risk

November 2, 2022

Hetero gets approval to make Roche’s tocilizumab in India under the brand name Tocira

September 12, 2021

Must Read

Why Every Pharma Company Needs a Unified Data Platform

August 29, 2026

AI-Powered Pharma Customer Engagement

August 29, 2026

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

August 29, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Another late-stage victory for Tezspire is achieved by AstraZeneca and Amgen, this time in esophagitis

Despite a mid-stage failure, Bausch + Lomb moves a medication for dry eye condition to Phase 3

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Definium Bags Major Phase 3 Victory With LSD Formula

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

Zealand Bags Huge Money By Selling Rights to Takeda’s Blood Cancer Drug

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Why Every Pharma Company Needs a Unified Data Platform

AI-Powered Pharma Customer Engagement

Top 10 Digital Risks Facing Biotech Companies

AI in GMP Compliance

Editorial Team

Eli Lilly Files Six Lawsuits Over Sales of Unapproved Retatrutide

Editor Picks

Incyte’s Opzelura Meets Primary Endpoint in Eczema Trial, but Safety Concerns Persist

Blood Pressure medication recalled due to cancer risk

Hetero gets approval to make Roche’s tocilizumab in India under the brand name Tocira

Must Read

Why Every Pharma Company Needs a Unified Data Platform

AI-Powered Pharma Customer Engagement

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

Hot Topics

About Us

Follow Us